Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Jasper Therapeutics Inc (JSPR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Jasper Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
21.590 -1.620    -6.98%
16:00:01 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 64,552
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 21.430 - 23.580
Jasper Therapeutics 21.590 -1.620 -6.98%

Jasper Therapeutics Inc Company Profile

 
Get an in-depth profile of Jasper Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

45

Equity Type

ORD

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company’s lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

Contact Information

Address 2200 Bridge Pkwy Suite 102
Redwood City, 94065
United States
Phone 650 549 1400
Fax -

Top Executives

Name Age Since Title
Kurt von Emster 55 2019 Independent Director
Christian W. Nolet 65 2021 Independent Director
Ronald A. Martell 61 2022 President, CEO & Director
Judith Anne Shizuru 66 2018 Co-Founder, Chair of Scientific Advisory Board & Director
Thomas G. Wiggans 71 2023 Chairman
Frederick R. Appelbaum - - Member of Scientific Advisory Board
Harry Malech - - Member of Scientific Advisory Board
Vishal Kapoor 47 2023 Independent Director
Scott C. Brun 55 2023 Director
Daniel C. Adelman 66 2023 Member of Scientific Advisory Board & Senior Clinical Advisor
Anna Louise French 35 2019 Independent Director
Arthur Weiss - - Member of Scientific Advisory Board
Jeffrey V. Ravetch 72 - Member of Scientific Advisory Board
Stephen J. Galli 76 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

JSPR Comments

Write your thoughts about Jasper Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sean Taylor
Sean Taylor Jan 10, 2023 8:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nice jump up. glad I held between 1.65 and 1.90
Sean Taylor
Sean Taylor Jan 04, 2023 7:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we reloading for $3.50 today guys???
Mitch
Mitch Jan 03, 2023 12:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Awesome trade! BJDX will make a similar move - get in before the FDA news is out!
Raul Garcia
Raul Garcia Jan 03, 2023 11:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
con tantas paradas no se puede, joer
Robert Kiel
Robert Kiel Jan 03, 2023 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Party
Raul Garcia
Raul Garcia Jan 03, 2023 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nadie en esta fiesta?
Scott Ornelas
Jatslo Oct 18, 2021 1:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JSPR (P) 0.00000000 16.41000000
Scott Ornelas
Jatslo Oct 14, 2021 11:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sold #JSPR @ 16.41000000
DW Chadz
Calgarychadz Oct 13, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A buy recommendation is that valuable?
Eric Grant
Eric Grant Oct 13, 2021 4:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JSPR Analyst RatingsCONSENSUSStrong BuyBased on 4 analysts offering recommendations for 'JSPR' in the last 3 months.
Batuhan Babür
Batuhan Babür Oct 13, 2021 1:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Missed it...
Giuseppe Giannachi
Giuseppe Giannachi Oct 13, 2021 1:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Same here
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email